FA
GWPH

Fagan Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Fagan Associates’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,520
Closed -$954K – 118
2018
Q3 		$954K Buy
5,520
+95
+2% +$13.7K 0.39% 62
2018
Q2 		$757K Buy
+5,425
New +$771K 0.34% 68

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fagan Associates's GWPH Position: Q4 2018 in Review

Fagan Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018, closing a stake of 5,520 shares — an estimated $954K sold.

Fagan Associates first reported a position in GWPH in Q2 2018 and held it in 2 quarters. The position peaked at $954K in Q3 2018. 277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

  • Fagan Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • Fagan Associates sold 5,520 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2018, an estimated $954K.
  • Fagan Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 2 quarters.
  • Fagan Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $954K in Q3 2018.
  • 277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on Fagan Associates's 13F filing for Q4 2018, filed 5 Feb 2019.